HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Herzig, M. C.S. Articles by Leeb-Lundberg, L. M.F. Search for Related Content PubMed PubMed Citation Articles by Herzig, M. C.S. Articles by Leeb-Lundberg, L. M.F. Social Bookmarking                      What's this?

Volume 271, Number 47, Issue of November 22, 1996 pp. 29746-29751
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

The N Terminus of Bradykinin When Bound to the Human Bradykinin B2 Receptor Is Adjacent to Extracellular Cys²⁰ and Cys²⁷⁷ in the Receptor

(Received for publication, July 3, 1996, and in revised form, September 13, 1996)

Maryanne C. S. Herzig , Norman R. Nash ^§ , Maureen Connolly ^¶ , Donald J. Kyle and L. M. Fredrik Leeb-Lundberg

From the  Department of Biochemistry, The University of Texas Health Science Center, San Antonio, Texas 78284, the ^§ Department of Neurology, Emory University, Atlanta, Georgia 30322, ^¶ Guilford Pharmaceuticals, Baltimore, Maryland 21224, and the  Department of Structural Biology and Medicinal Chemistry, Scios Inc., Sunnyvale, California 94086

Chemical cross-linking combined with site-directed mutagenesis was used to evaluate the role of extracellular cysteines and their positions relative to the binding site for the agonist bradykinin (BK) in the human BK B2 receptor. All extracellular cysteines, Cys²⁰, Cys¹⁰³, Cys¹⁸⁴, and Cys²⁷⁷, in the receptor were mutated to serines, and single and double mutants were transfected into COS-7 cells. The Ser²⁰ and Ser²⁷⁷ single mutants and the Ser²⁰/Ser²⁷⁷ double mutant bound [³H]BK and the antagonist [³H]NPC17731 with pharmacological profiles identical to the wild-type B2 receptor. In contrast, the Ser¹⁰³ and Ser¹⁸⁴ single mutants were unable to bind either of the two radioligands. However, these mutants were still expressed as determined by immunoblotting with anti-B2 receptor antibodies. Previous studies on the bovine B2 receptor showed that bifunctional reagents, which are reactive to amines at one end and to free sulfhydryls in the opposite end, cross-link the N terminus of receptor-bound BK to a sulfhydryl in the receptor (Herzig, M. C. S., and Leeb-Lundberg, L. M. F. (1995) J. Biol. Chem. 270, 20591-20598). Here, we show that m-maleimidobenzoyl-N-hydroxysuccinimide ester and 1,5-difluoro-2,4-dinitrobenzene cross-linked BK to the wild-type human B2 receptor and the Ser²⁰ and Ser²⁷⁷ single mutant receptors, whereas these reagents were unable to cross-link BK to the Ser²⁰/Ser²⁷⁷ double mutant. These results show that Cys¹⁰³ and Cys¹⁸⁴ are both required for expression of high affinity agonist and antagonist binding sites in the human B2 receptor, while Cys²⁰ and Cys²⁷⁷ are not required. Furthermore, the results provide direct biochemical evidence that the N terminus of BK, when bound to the B2 receptor, is adjacent to Cys²⁷⁷ in extracellular domain 4 and Cys²⁰ in extracellular domain 1 of the receptor.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77. [Abstract] [Full Text] [PDF]

				N. S. Green, E. Reisler, and K.N. Houk Quantitative evaluation of the lengths of homobifunctional protein cross-linking reagents used as molecular rulers Protein Sci., July 1, 2001; 10(7): 1293 - 1304. [Abstract] [Full Text] [PDF]

				S. Bastian, D. Pruneau, B. Loillier, C. Robert, J.-C. Bonnafous, and J.-L. Paquet Identification of a Key Region of Kinin B1 Receptor for High Affinity Binding of Peptide Antagonists J. Biol. Chem., February 25, 2000; 275(9): 6107 - 6113. [Abstract] [Full Text] [PDF]

				D. B. Fathy, D. J. Kyle, and L. M. F. Leeb-Lundberg High-Affinity Binding of Peptide Agonists to the Human B1 Bradykinin Receptor Depends on Interaction between the Peptide N-Terminal L-Lysine and the Fourth Extracellular Domain of the Receptor Mol. Pharmacol., January 1, 2000; 57(1): 171 - 179. [Abstract] [Full Text]

				H. H. Ho, D. Du, and M. C. Gershengorn The N Terminus of Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor Is Necessary for High Affinity Chemokine Binding but Not for Constitutive Activity J. Biol. Chem., October 29, 1999; 274(44): 31327 - 31332. [Abstract] [Full Text] [PDF]

				D. B. Fathy, S. A. Mathis, T. Leeb, and L. M. F. Leeb-Lundberg A Single Position in the Third Transmembrane Domains of the Human B1 and B2 Bradykinin Receptors Is Adjacent to and Discriminates between the C-terminal Residues of Subtype-selective Ligands J. Biol. Chem., May 15, 1998; 273(20): 12210 - 12218. [Abstract] [Full Text] [PDF]

				F. S. Monteclaro and I. F. Charo The Amino-terminal Domain of CCR2 Is Both Necessary and Sufficient for High Affinity Binding of Monocyte Chemoattractant Protein 1. RECEPTOR ACTIVATION BY A PSEUDO-TETHERED LIGAND J. Biol. Chem., September 12, 1997; 272(37): 23186 - 23190. [Abstract] [Full Text] [PDF]

				T. Leeb, S. A. Mathis, and L. M.F. Leeb-Lundberg The Sixth Transmembrane Domains of the Human B1 and B2 Bradykinin Receptors Are Structurally Compatible and Involved in Discriminating between Subtype-selective Agonists J. Biol. Chem., January 3, 1997; 272(1): 311 - 317. [Abstract] [Full Text] [PDF]